APDN アプライド・DNA・サイエンシズ
- 0.177
- -0.010-5.29%
- 0.178
- +0.001+0.40%
アプライド・DNA・サイエンシズのニュース一覧
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced From Linea DNA
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday
10-K：有価証券報告書
Applied DNA Sciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Sales Results and Announced Plans for a Strategic Restructuring of Operations Including Divestiture of Certain Business Segments.
8-K：Applied DNAが第4四半期と2024会計年度の決算を発表、遺伝子医薬品の重要な出発物質の製造を優先するための戦略的再編を発表
Applied DNA Reveals Immediate Promotion Of COO Judith Murrah To President; James Hayward Remains Chairman Of Board And CEO
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q4 Revenue $813,106, Vs. Street Est of $0.9M
Earnings Scheduled For December 17, 2024
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide With Update on GMP Manufacturing Facility Build-out
WHO Extends Mpox Emergency; Canada Reports First Clade I Case
World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern
APDN Files for Resale of 41.6 Million Shares by Selling Stockholders
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast
12 Health Care Stocks Moving In Wednesday's Intraday Session
First Mpox Case Linked to African Outbreak Reported in U.K.
Dow Surges Over 150 Points; Alphabet Posts Upbeat Results
Why Applied DNA Sciences (APDN) Stock Is Down 37% Today
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
データなし
